François Mongrain
Chief Executive Officer at Mimetogen Pharmaceuticals, Inc.
Network origin in François Mongrain first degree
Entity | Entity type | Industry | |
---|---|---|---|
Laurent Pharmaceuticals, Inc.
Laurent Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Laurent Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm develops clinical stage, orally-active drug candidate with potential to modulate the immuno-inflammatory response in cystic fibrosis patients. The company was founded in 2012 and is headquartered in Montr?al, Canada.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Mimetogen Pharmaceuticals, Inc.
Mimetogen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Mimetogen Pharmaceuticals, Inc. develops peptidomimetic small molecule drugs against glaucoma and cancer. Its product mimic the effects of neurotrophin proteins that help to maintain the health and growth of cells and tissues found in the eye. Mimetogen provides tyrosine kinase agonists that prevent neuronal death; small molecule tyrosine kinase receptor agonists, which stimulates mucin secretion from conunctival goblet cells; and small molecule neurotrophin mimetics that rescues retinal pigment epithelial cells from oxidative stress-induced apoptosis. The company was founded by Garth Cumberlidge and H. Uri Saragovi in 2005 and is headquartered in Montreal, Canada.
3
| Holding Company | Pharmaceuticals: Major | 3 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to François Mongrain via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
University of Alberta | College/University | Undergraduate Degree Graduate Degree | |
APPLIED GENETIC TECHNOLOGIES CORPORATION | Pharmaceuticals: Generic | Director/Board Member | |
Sound Pharmaceuticals, Inc.
Sound Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sound Pharmaceuticals Inc. manufactures biopharmaceutical products. It focuses on developing drug treatments for sensori-neural hearing loss. The company was founded by Eric Lynch, Joseph Ashley, Glenn H. Kawasaki and Jonathan Kil in 2001 and is headquartered in Seattle, WA. | Pharmaceuticals: Major | Director/Board Member | |
iSTAR Medical SA
iSTAR Medical SA Medical SpecialtiesHealth Technology iSTAR Medical SA develops innovative ophthalmic implants. Its products include MINIject, STARflo and STAR Material. The company was founded by Michel Alvarez in 2011 and is headquartered in Wavre, Belgium. | Medical Specialties | Director/Board Member | |
The Johns Hopkins University School of Medicine | College/University | Doctorate Degree | |
New York University School of Medicine | College/University | Corporate Officer/Principal | |
Yale College | College/University | Undergraduate Degree | |
Carter BloodCare
Carter BloodCare Miscellaneous Commercial ServicesCommercial Services Carter BloodCare engages in the provision of blood components and transfusion services for North, Central and East Texas. It offers collection, testing, and distribution of blood on a local level. It also provides technical support services and educational programs to employees of area healthcare organizations. The company was founded on January 1, 1998 and is headquartered in Bedford, TX. | Miscellaneous Commercial Services | Director/Board Member | |
OXURION NV | Pharmaceuticals: Major | Director/Board Member | |
Invectys, Inc.
Invectys, Inc. Pharmaceuticals: MajorHealth Technology Invectys, Inc. is a biopharmaceutical company that focuses on developing immunotherapy treatments for cancer. The private company is based in Houston, TX. Invectys was founded in 2010 and Praveen Tyle has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
SV Health Investors LLC
SV Health Investors LLC Investment ManagersFinance SV Health Investors LLC is a Venture Capital firm, a subsidiary of SV Health Investors LLP founded in 2006. SV Health Investors LLC is headquartered in Boston. | Investment Managers | Private Equity Investor | |
AlloCure, Inc.
AlloCure, Inc. BiotechnologyHealth Technology AlloCure, Inc. develops cell therapies for the treatment of kidney diseases. It engages in developing allogeneic mesenchymal stem cell therapy for acute kidney injury. The company was founded in 2008 and is headquartered in Burlington, MA. | Biotechnology | Director/Board Member | |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Biotechnology | Founder | |
Imagen Biotech, Inc.
Imagen Biotech, Inc. Pharmaceuticals: MajorHealth Technology Imagen Biotech, Inc. develops therapeutics for sight-threatening diseases. The firm specializes in personalized chemotherapy, medicine, high content screening, cell biology and contract research. The company was founded by David R. Guyer and Matthew Feinsod in 2011 and is headquartered in New York, NY. | Pharmaceuticals: Major | Founder | |
PanOptica, Inc.
PanOptica, Inc. Pharmaceuticals: MajorHealth Technology PanOptica, Inc. operates as a biopharmaceutical company that provides ophthalmology drugs for treatment of eye diseases. The company was founded by Paul G. Chaney and Martin B. Wax in March 2009 and is headquartered in Bernardsville, NJ. | Pharmaceuticals: Major | Director/Board Member | |
OPTOS PLC | Medical Specialties | Director/Board Member | |
EYEPOINT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Visus Therapeutics, Inc.
Visus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Visus Therapeutics, Inc. is a clinical stage biopharmaceutical company that focuses on developing multi-targeted ophthalmic therapeutics for the front and back of the eye. The company is based in Seattle, WA and has subsidiaries in the United States. The company is developing novel, pupil-modulating therapeutics designed to correct the loss of near vision associated with presbyopia. In parallel, Visus is advancing its pipeline of early-stage ophthalmic drug candidates engineered to preserve and restore visual function associated with the leading causes of vision loss including cataract and presbyopia, ocular surface and corneal disease, glaucoma, and age-related macular degeneration. The company was founded by Benjamin Scot Bergo, Rhett M. Schiffman, and Benjamin Scot Bergo has been the CEO since incorporation. | Pharmaceuticals: Major | Chairman | |
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Shire BioChem, Inc.
Shire BioChem, Inc. Medical DistributorsDistribution Services Shire BioChem, Inc. provides pharmaceutical sales and marketing services in Canada. The company is headquartered in Laval, Canada. | Medical Distributors | Chief Tech/Sci/R&D Officer | |
McGill University | College/University | Doctorate Degree | |
iNovia Capital, Inc.
iNovia Capital, Inc. Investment ManagersFinance iNovia Capital, Inc., formerly MSBi Capital, is a venture capital firm founded in 2001 by Shawn Abbott. The firm is headquarters in Montreal Canada. | Investment Managers | Private Equity Analyst | |
Otsuka Canada Pharmaceutical, Inc.
Otsuka Canada Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Canada Pharmaceutical, Inc. is a Canadian healthcare company that commercializes Otsuka medicines in Canada, with a focus on neuroscience and nephrology. The company is based in Saint-Laurent, Canada and was founded in 1921. The company is dedicated to improving patients' health and the quality of human life. Otsuka Pharmaceutical Co., Ltd., the parent company, is a healthcare company with the corporate philosophy of creating new products for better health worldwide. | Pharmaceuticals: Major | Director/Board Member | |
HEC Montréal | College/University | Masters Business Admin | |
University of Montréal | College/University | Undergraduate Degree | |
Abbott Laboratories Co.
Abbott Laboratories Co. Pharmaceuticals: MajorHealth Technology Abbott Laboratories Co. provides health care services. The firm conducts research and manufactures products for human health through every life stage. Its products include nutrition, diagnostics, vascular and diabetes care. The company is headquartered in Saint-Laurent, Canada. | Pharmaceuticals: Major | President | |
Eyebiotech Ltd.
Eyebiotech Ltd. BiotechnologyHealth Technology Eyebiotech Ltd. is a British clinical stage ophthalmology company that treats patients with sight-threatening diseases. The company is based in London, UK. Eyebiotech was founded in 2021 by David R. Guyer and Anthony P. Adamis. David R. Guyer has been the CEO since 2021. | Biotechnology | Chief Executive Officer | |
AETERNA ZENTARIS INC. | Pharmaceuticals: Major | Chief Operating Officer | |
MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Rhone Poulenc Rorer
Rhone Poulenc Rorer Chemicals: SpecialtyProcess Industries Part of Solvay SA, Rhone Poulenc Rorer is a French pharmaceutical company that manufactures and distributes pharmaceutical products. | Chemicals: Specialty | President | |
THERATECHNOLOGIES INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Tenpoint Therapeutics Ltd.
Tenpoint Therapeutics Ltd. BiotechnologyHealth Technology Tenpoint Therapeutics Ltd. is a British biotechnology company that specializes in developing engineered cell-based therapies and in vivo reprogramming to restore vision for individuals with degenerative ocular diseases. The company is based in Cambridge, UK and was founded in 2020. Tenpoint Therapeutics brings together experts who are shaping the regenerative ocular medicine revolution and the technologies that are driving it. The company's focus is on replacing diseased cells with healthy ones to permanently restore vision. Eddy Anglade has been the CEO of the company since 2023. | Biotechnology | Chairman | |
Danube Pharmaceuticals, Inc.
Danube Pharmaceuticals, Inc. BiotechnologyHealth Technology Danube Pharmaceuticals, Inc. provides bio pharmaceutical services. It engages in the discovery and development of therapies and devices for ophthalmology. The firm's products include DNB-001, a small molecule for the treatment of glaucoma. The company was founded in 2006 and is headquartered in New York, NY. | Biotechnology | Chairman | |
Neurotech Pharmaceuticals, Inc. (United States)
Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Director/Board Member | |
Medwell Partnership GP Ltd. | Chief Executive Officer | ||
Anapharm, Inc.
Anapharm, Inc. Miscellaneous Commercial ServicesCommercial Services Anapharm, Inc. is a hospital and health care company. It provides clinical trials and bioanalytical research services. The company is headquartered in Québec, Canada. | Miscellaneous Commercial Services | Founder | |
ML Royalties LP
ML Royalties LP Finance/Rental/LeasingFinance ML Royalties LP provides quality car care services. The company was founded by Cliff D. Giese in 2002 and is headquartered in Richmond,Canada. | Finance/Rental/Leasing | Director/Board Member | |
Mr Lube Canada Gp, Inc.
Mr Lube Canada Gp, Inc. Other Consumer ServicesConsumer Services Mr Lube Canada Gp, Inc. provides automotive repair and maintenance services. The firm's services include fluid changes: engine oil, transmission, coolant, differential and transfer case; filter replacements: air, cabin air, fuel and emission; other products and services: batteries, serpentine belts, emission, valves, wiper blades, tire services, windshield chip repair, headlights and taillights, fuel system cleaning, engine flush, and a variety of preventive care and performance additives. The company was founded by Arnold Giese and Clifford D. Giese in 1976 and is headquartered in Richmond, Canada. | Other Consumer Services | Director/Board Member | |
GDI INTEGRATED FACILITY SERVICES INC. | Miscellaneous Commercial Services | Director/Board Member | |
The Schulich School of Business | College/University | Masters Business Admin | |
Mr. Lube Services | President | ||
Medwell Healthcare Investments LP | Chief Executive Officer | ||
FRX Polymers, Inc.
FRX Polymers, Inc. Chemicals: SpecialtyProcess Industries FRX Polymers, Inc. manufactures flame retardant plastics and additives. Its products include homopolymers, copolymers and oligomers additive and oligomers reactive. The firm serves fibers, electrical equipment and consumer electronics, transportation, building and construction markets. The company was founded by Marc A. Lebel and Ross Haghighat in 2007 and is headquartered in Chelmsford, MA. | Chemicals: Specialty | Chief Executive Officer | |
L'Institut des administrateurs de sociétés, section du Québec
L'Institut des administrateurs de sociétés, section du Québec Miscellaneous Commercial ServicesCommercial Services IAS Québec Chapter operates as an association of Canadian directors and boards. It offers director education and professional certification. The institute was founded in 2003 and is headquartered in Montréal, Canada. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Victoria | College/University | Graduate Degree |
Statistics
International
Canada | 24 |
United States | 21 |
United Kingdom | 4 |
Belgium | 3 |
France | 3 |
Sectoral
Health Technology | 26 |
Consumer Services | 11 |
Finance | 5 |
Commercial Services | 5 |
Process Industries | 3 |
Operational
Director/Board Member | 36 |
President | 16 |
Chief Executive Officer | 12 |
Corporate Officer/Principal | 10 |
Chairman | 9 |
Most connected contacts
Insiders | |
---|---|
David Guyer | 27 |
Kevin A. Giese | 18 |
Marc-Andre Lebel | 18 |
Yves Rosconi | 11 |
Karen Meerovitch | 5 |
Radu Pislariu | 2 |
- Stock Market
- Insiders
- François Mongrain
- Company connections